Paul Hartmann AG
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Paul Hartmann AG - overview
Established
1818
Location
-, -, Germany
Primary Industry
Medical Devices & Equipment
About
Based in Germany, Paul Hartmann AG operates as a leading provider of medical and hygiene products, focusing on wound care, surgical supplies, and incontinence management for healthcare professionals globally. Founded in 1818, Paul Hartmann AG specializes in medical and hygiene products. The company is headquartered in Heidenheim, Germany. It has evolved over the years to adapt to the changing landscape of healthcare and has expanded its global presence without any mentioned pivots or changes in business strategy.
The current leadership includes CEOs Britta Fuenfstueck, Jaime Hauan, Niels Hartmann, and Panos Rohlf. HARTMANN specializes in the production and distribution of high-quality medical and hygiene products, focusing on areas such as wound care, incontinence management, and surgical supplies. Their core offerings include advanced wound dressings, absorbent products for incontinence, and specialized surgical equipment. These products are designed to address critical healthcare needs, such as facilitating wound healing, managing incontinence with dignity, and ensuring safety during surgical procedures.
HARTMANN's products are utilized by healthcare professionals in hospitals, clinics, and home care settings across various global markets, including Europe, North America, Asia, and parts of Africa. The company's commitment to innovation is evident in its ongoing development of advanced materials and technologies, ensuring that their products meet the evolving needs of healthcare providers and patients alike. In 2022, HARTMANN reported a revenue of EUR 1,110,185,567. 20 and an EBITDA of EUR 61,967,590.
30. The company generates revenue through a multi-faceted transaction structure that involves direct sales to healthcare institutions and partnerships with distributors, retailers, and wholesalers. HARTMANN engages in B2B transactions, supplying its medical products to hospitals and health facilities, while also establishing partnerships with local distributors to expand its market reach. Their flagship products, including advanced wound care solutions and incontinence products, are integral to their revenue model, providing steady demand from healthcare providers seeking reliable and effective solutions.
Primary Industry
Medical Devices & Equipment
Sub Industries
Beauty & Hygiene, Medical Supplies, Specialty Pharmaceuticals
Website
www.hartmann.info
Verticals
E-commerce, Manufacturing
Total Amount Raised
Subscriber access only
Paul Hartmann AG - timeline of key events
Paul Hartmann AG - financials
| Fiscal Year Ended | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 1,699,404,000 | 1,758,377,000 | 1,794,442,000 | 1,862,035,000 | 1,941,004,000 | 1,986,450,000 | 2,058,628,000 | 2,119,103,000 | 2,186,765,000 | - | - | - | - |
| % Revenue Growth (YoY) | - | 3.5% | 2.1% | 3.8% | 4.2% | 2.3% | 3.6% | 2.9% | 3.2% | - | - | - | - |
| EBITDA (USD) | 159,209,000 | 144,014,000 | 157,905,000 | 184,352,000 | 200,313,000 | 211,659,000 | 206,176,000 | 194,490,000 | 211,014,000 | - | - | - | - |
| Operating Income (USD) | 107,055,000 | 86,269,000 | 102,054,000 | 123,524,000 | 133,996,000 | 139,942,000 | 139,605,000 | 124,181,000 | 105,045,000 | - | - | - | - |
| Operating Margin | 6.3% | 4.9% | 5.7% | 6.6% | 6.9% | 7.0% | 6.8% | 5.9% | 4.8% | - | - | - | - |
| % EBITDA Margin | 9.4% | 8.2% | 8.8% | 9.9% | 10.3% | 10.7% | 10.0% | 9.2% | 9.6% | - | - | - | - |
| NET Income (USD) | 70,762,000 | 55,422,000 | 62,477,000 | 78,347,000 | 84,778,000 | 90,100,000 | 93,704,000 | 83,774,000 | 62,930,000 | - | - | - | - |
| % Net Margin | 4.2% | 3.2% | 3.5% | 4.2% | 4.4% | 4.5% | 4.6% | 4.0% | 2.9% | - | - | - | - |
Paul Hartmann AG - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Sanimed GmbH | - |
Displaying 1 - 1 of 1
Paul Hartmann AG - employee data
Paul Hartmann AG - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Board Member and CEO | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.